FDA Approved: CELECOXIB — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for celecoxib from Apotex Corp., granting approval for a generic version of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

SUPPL AP for CELECOXIB (CELECOXIB)